Patent details

EP4566591 Title: SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING EZETIMIBE AND PITAVASTATIN

Basic Information

Publication number:
EP4566591
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP232148163
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING EZETIMIBE AND PITAVASTATIN
French Title of Invention:
FORME PHARMACEUTIQUE SOLIDE COMPRENANT DE L'ÉZÉTIMIBE ET DE LA PITAVASTATINE
German Title of Invention:
FESTE PHARMAZEUTISCHE DARREICHUNGSFORM MIT EZETIMIBE UND PITAVASTATIN
SPC Number:

Dates

Filing date:
07/12/2023
Grant date:
31/12/2025
EP Publication Date:
11/06/2025
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/12/2025
EP B1 Publication Date:
31/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
07/12/2043
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/12/2025
 
 

Name:
KRKA, d.d., Novo mesto
Address:
Smarjeska cesta 6, 8501 Novo mesto, Slovenia (SI)

Inventor

1

Name:
BAJC, Grega
Address:
Slovenia (SI)

2

Name:
OMERZU, Maja
Address:
Slovenia (SI)

3

Name:
KROSELJ, Vesna
Address:
Slovenia (SI)

4

Name:
KOSMAC, Ina
Address:
Slovenia (SI)

5

Name:
DEBELJAK SIMONCIC, Kristina
Address:
Slovenia (SI)

Classification

IPC classification:
A61K 9/20; A61K 9/16; A61K 45/06; A61K 31/397; A61K 31/47; A61P 3/06;

Publication

European Patent Bulletin

Issue number:
202601
Publication date:
31/12/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2026
Annual Fee Number:
4
Annual Fee Amount:
41 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages